Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥3,925 JPY
Change Today -211.00 / -5.10%
Volume 1.3M
4578 On Other Exchanges
Symbol
Exchange
Tokyo
Berlin
OTC US
As of 12:37 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

otsuka holdings co ltd (4578) Snapshot

Open
¥4,101
Previous Close
¥4,136
Day High
¥4,107
Day Low
¥3,924
52 Week High
08/6/15 - ¥4,774
52 Week Low
02/16/15 - ¥3,433
Market Cap
2.2T
Average Volume 10 Days
2.0M
EPS TTM
¥246.26
Shares Outstanding
557.8M
EX-Date
12/28/15
P/E TM
15.9x
Dividend
¥100.00
Dividend Yield
2.30%
Current Stock Chart for OTSUKA HOLDINGS CO LTD (4578)

Related News

No related news articles were found.

otsuka holdings co ltd (4578) Related Businessweek News

View More BusinessWeek News

otsuka holdings co ltd (4578) Details

Otsuka Holdings Co., Ltd. operates in pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company’s Pharmaceutical segment provides healthcare solutions in the areas of central nervous system, oncology, cardiovascular system, gastroenterology, respiratory system, infectious disease, ophthalmology, dermatology, allergies, and urology. This segment also offers intravenous solutions, enteral nutrition, and contract manufacturing services; influenza diagnostic agents, Helicobacter pylori test kits, and other products; and apheresis device for leukocyte adsorption, drug-eluting stents, and other products. Its Nutraceuticals segment engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy bars, carbonated soy beverages, soy snacks, equol-containing food, dietary food, and OTC products. The company’s Consumer Products offers segment beverages, foods, and alcoholic beverages. Its Other Businesses segment provides chemical materials for the automotive, electrical, electronic, and building materials sectors; and transport and warehousing services for pharmaceuticals, foods, and beverages. This segment also researches and develops flat panel displays, equipment for optical evaluation/inspection of FPDs and constituent materials, medical equipment, and clinical diagnostic equipment. The company was founded in 1921 and is headquartered in Tokyo, Japan.

Founded in 1921

otsuka holdings co ltd (4578) Top Compensated Officers

Chief Executive Officer, President and Repres...
Total Annual Compensation: ¥161.0M
Compensation as of Fiscal Year 2014.

otsuka holdings co ltd (4578) Key Developments

Otsuka Holdings Co., Ltd., H1 2015 Earnings Call, Aug 07, 2015

Otsuka Holdings Co., Ltd., H1 2015 Earnings Call, Aug 07, 2015

Otsuka Holdings Co., Ltd. Reports Consolidated Earnings Results for the Six Months Ended June 30, 2015; Revises Consolidated Earnings Guidance for the Year Ending December 31, 2015; Announces Dividend for the Six Months Ended June 30, 2015, Payable on September 7, 2015; Provides Dividend Guidance for the Year Ending December 31, 2015

Otsuka Holdings Co., Ltd. reported consolidated earnings results for the six months ended June 30, 2015. For the period, the company reported net sales of JPY 745,804 million against JPY 788,283 million a year ago. Operating income was JPY 103,159 million against JPY 136,650 million a year ago. Ordinary income was JPY 109,382 million against JPY 148,124 million a year ago. Net income was JPY 69,474 million against JPY 99,503 million a year ago. Diluted earnings per share were JPY 128.20 against JPY 183.64 a year ago. Income before income taxes and minority interests was JPY 109,471 million against JPY 147,525 million a year ago. Net cash provided by operating activities was JPY 227,522 million against JPY 80,232 million a year ago. This was mainly due to JPY 109,471 million in income before income taxes and minority interest, a JPY 91,931 million decrease in trade receivables, and JPY 23,821 million in depreciation and amortization. Purchases of property, plant and equipment was JPY 31,748 million against JPY 19,684 million a year ago. Purchases of intangible assets were JPY 12,843 million against JPY 4,252 million a year ago. For the fiscal year ending December 31, 2015, on consolidated basis, the company expects net sales of JPY 1,380,000 million, operating income of JPY 120,000 million, ordinary income of JPY 125,000 million, net income of JPY 80,000 or basic earnings per share was JPY 147.65 compared to previous forecast net sales of JPY 1,370,000 million, operating income of JPY 110,000 million, ordinary income of JPY 120,000 million, net income of JPY 80,000 or basic earnings per share was JPY 147.65. The company announced dividend of JPY 50 per share for the six months ended June 30, 2015. Scheduled date of dividend payment commencement is September 7, 2015. The company provided dividend guidance for the year ending December 31, 2015. For the year, the company expects year-end dividend of JPY 50 per share compared to paid dividend of JPY 40 per share a year ago.

Otsuka Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Year Ending June 30, 2015

Otsuka Holdings Co., Ltd. revised consolidated earnings guidance for the first half year ending June 30, 2015. For the first half, the company expects net sales of JPY 745,000 million, operating income of JPY 100,000 million, ordinary income of JPY 105,000 million and net income of JPY 65,000 million or JPY 119.96 per share compared to previous guidance of net sales of JPY 710,000 million, operating income of JPY 55,000 million, ordinary income of JPY 60,000 million and net income of JPY 40,000 million or JPY 73.82 per share. Consolidated operating income, ordinary income and net income are projected to exceed the previous forecast as a result of stronger growth of the pharmaceutical business in the U.S., recognition of a milestone payment from H. Lundbeck A/S for brexpiprazole in the first half, which was previously forecast to occur in the second half, and decreases in research and development expenses due to the development plan changes.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4578:JP ¥3,924.50 JPY -211.00

4578 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4578.
View Industry Companies
 

Industry Analysis

4578

Industry Average

Valuation 4578 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 1.3x
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OTSUKA HOLDINGS CO LTD, please visit www.otsuka.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.